Newsfeeds - Spark Newswire

1 minute read

ProKidney Turns To Palihapitiya-Backed SPAC To Go Public In $2.6B Deal

Today, 10:08 PM

ProKidney LP agreed to become a publicly-traded company via a business combination with Chamath Palihapitiya-backed special purpose acquisition company Social Capital Suvretta Holdings Corp III (NASDAQ: DNAC) in a deal valuing the

DNAC

3 minute read

2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year’s First Deal Once Again?

By Chris Katje

Today, 10:08 PM

The 2022 year has started quietly for SPACs, with no deals announced in the first five trading days of the year. Although two new SPAC rumors have popped up since the market closed on Friday and both involve a well-known name in the SPAC space.

AMGN

3 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 10:08 PM

Before 10 a.m. ET on Friday, 29 stocks hit new 52-week lows.

ALZN

1 minute read

List Of Initial Public Offerings For Today, June. 30, 2021

By Michael Horton

Today, 10:08 PM

DiDi Global (DIDI) SentinelOne (S) Clear Secure (YOU) Aerovate Therapeutics (AVTE) Social Capital Suvretta I (DNAA) Social Capital Suvretta II (DNAB) Social Capital Suvretta III (DNAC) Social Capital Suvretta IV

AVTE

2 minute read

Chamath Palihapitiya Launches 4 New Biotech SPACs: What Investors Should Know

By Chris Katje

Today, 10:08 PM

One of the most famous voices in the SPAC industry is launching four new SPACs and also making several changes to his existing lineup of SPACs and former SPACs. What Happened: Chamath Palihapitiya is launching four new SPACs targeting the biotechnology sector. Each SPAC is seeking to raise $200 million and will not contain warrants.

CLOV

Latest news

ProKidney Turns To Palihapitiya-Backed SPAC To Go Public In $2.6B Deal

2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year’s First Deal Once Again?

Stocks That Hit 52-Week Lows On Friday

List Of Initial Public Offerings For Today, June. 30, 2021

Chamath Palihapitiya Launches 4 New Biotech SPACs: What Investors Should Know